PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-6.78%
Negative net income growth while ZETA stands at 40.68%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
10.60%
Some D&A expansion while ZETA is negative at -1.61%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-68.11%
Negative yoy deferred tax while ZETA stands at 53.19%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
3.61%
Less SBC growth vs. ZETA's 10.68%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
182.16%
Working capital change of 182.16% while ZETA is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might affect near-term cash flow.
171.81%
AR growth while ZETA is negative at -367.30%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-94.43%
Negative yoy usage while ZETA is 100.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-119.24%
Both negative yoy, with ZETA at -192.80%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
55.07%
Operating cash flow growth above 1.5x ZETA's 20.83%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-9.21%
Negative yoy CapEx while ZETA is 14.14%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
68.13%
Some acquisitions while ZETA is negative at -26.79%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
44.89%
Purchases growth of 44.89% while ZETA is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-54.07%
We reduce yoy sales while ZETA is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
140.13%
We have some outflow growth while ZETA is negative at -39.54%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
25.83%
We have mild expansions while ZETA is negative at -18.84%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
-88.52%
Negative yoy issuance while ZETA is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
69.44%
We have some buyback growth while ZETA is negative at -23.83%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.